Evidence map›Paper›PMID 39569424›Full record

ArticleThe Journal of infectious diseases2025

Impact of Multicohort Human Papillomavirus Vaccination on Cervical Cancer in Women Below 30 Years of Age: Lessons Learned From the Scandinavian Countries.

Ståle Nygård, Thea Eline Hetland Falkenthal, Tina Sture, Elsebeth Lynge, Miriam Elfström, Mari Nygård

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in The Journal of infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ståle NygårdDepartment of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.ORCID 0000-0002-5263-4748
Thea Eline Hetland FalkenthalDepartment of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.ORCID 0009-0009-0198-0761
Tina StureDepartment of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.ORCID 0009-0007-5603-8314
Elsebeth LyngeZealand University Hospital, Nykøbing Falster, Denmark.
Miriam ElfströmCenter of Cervical Cancer Elimination, Department of Clinical Science Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Mari NygårdDepartment of Research, Cancer Registry of Norway, Norwegian Institute of Public Health, Oslo, Norway.

Funding

MSD Norway
6 · The paper itself

Abstract

In Scandinavia, human papillomavirus (HPV) vaccination programs started in 2007-2008 in Sweden and Denmark with HPV vaccination offered to multiple cohorts of young girls, while in Norway this was offered to a single cohort only. Interestingly, in Sweden and Denmark, cervical cancer incidence in young women decreased markedly from 2017 to 2018, while in Norway a steady increase was seen until 2020. As the 3 countries are very similar in other factors important for cervical cancer incidence rates, like cervical cancer screening, the observed difference is most likely due to differences in the multicohort vaccination.

Indexed as

Papillomavirus InfectionsPapillomavirus VaccinesUterine Cervical NeoplasmsVaccinationAdolescentAdultDenmarkFemaleHuman Papillomavirus VirusesHumansIncidenceNorwayScandinavian and Nordic CountriesSwedenYoung AdultPapillomavirus Vaccinescervical cancer incidence rateshuman papillomavirus (HPV)multicohort vaccinationScandinavian countriessingle-cohort vaccination

Identifiers

PMID39569424
PMCPMC11911778

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.